Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
PhOx-430 by Phost'IN for Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer): Likelihood of Approval
PhOx-430 is under clinical development by Phost'IN and currently in Phase II for Human Epidermal Growth Factor Receptor 2 Negative...
Data Insights
PhOx-430 by Phost'IN for Solid Tumor: Likelihood of Approval
PhOx-430 is under clinical development by Phost'IN and currently in Phase II for Solid Tumor. According to GlobalData, Phase II...